Welcome to Bayside Health | Alfred. More information about Bayside Health can be found at baysidehealth.org.au

Contact About Find a doctor Careers The Alfred Foundation For staff

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 700 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials

Clear filter

637 clinical trials found

Clinical trials

SISS

Switching patients from intravenous to subcutaneous infliximab in inflammatory bowel disease (ACTRN12621001498886)

Currently recruiting

Skinomics

A non-interventional research study of the alterations in the microbiome in inflammatory skin disease (Trial Not Registered)

This study aims to investigate immune reactions that can be involved in atopic dermatitis (eczema). It will do this by examining the composition and differences in the microorganisms, gene expression (regulated processes that allow a cell to respond to its changing environment) and lipids/metabolites (small proteins, sugars or fats produced by cells) of people with eczema vs. people without. This will potentially support more personalised and effective treatments for people with eczema and ultimately improve patient care.

Currently recruiting

SLN124-004

Phase 1/2 study with an open-label dose escalation phase followed by a randomized, double-blind phase of SLN124 in patients with Polycythemia Vera (NCT05499013)

No longer recruiting

SMITE

SMITE: Superiority of Migraine Inpatient Treatment with Eptinezumab (ACTRN12621001616864)

No longer recruiting

SNAP

Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)

Currently recruiting

SNaPP Study

Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)

No longer recruiting

SNDX-5613-0700

A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients with Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or Nucleophosmin 1 (NPM1) Mutation (NCT04065399)

Currently recruiting

SNDX-5613-0708

Phase 1, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of SNDX-5613 in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed Acute Myeloid Leukemias Harboring Alterations in Lysine-specific Methyltransferase 2A [KMT2A/MLL], Nucleophosmin 1 [NPM1], and Nucleoporin 98 [NUP98] Genes (NCT06226571)

Currently recruiting

SNDX-5613-0710

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Intensive Chemotherapy in Participants with Newly Diagnosed AML with an NPM1 mutation [REVEAL-ND NPM1] (NCT07211958)

The purpose of this study is to assess if adding revumenib to standard chemotherapy improves outcomes in participants with AML with certain genetic mutations compared to chemotherapy alone. The study will also assess the safety of adding revumenib to chemotherapy.

Coming soon

SNIPER

Stereotactic ablative body radiation therapy with Nodal Irradiation for ProstatE canceR (ACTRN12625000259448)

Currently recruiting

SNV1521

A PHASE 1, OPEN-LABEL DOSE ESCALATION AND EXPANSION STUDY OF SNV1521 IN PARTICIPANTS WITH ADVANCED SOLID TUMORS (NCT06220864)

Currently recruiting

SOCRATES

A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (ACTRN12621001444875p)

Currently recruiting

SODa-BIC

SODa-BIC: Sodium Bicarbonate For Metabolic Acidosis in the Intensive Care Unit, A Multicentre, Randomised, Double-Blind Clinical Trial (NCT05697770)